Cryotherapy, or cryosurgery (freezing), uses extreme cold to treat sunspots, some small superficial basal cell carcinomas (BCCs) and squamous cell carcinomas (SCC) in situ (Bowen’s disease). It is not suitable for some SCCs that have come back.
How it’s done
The GP or dermatologist sprays liquid nitrogen onto the sunspot or skin cancer and a small area of skin around it. You may feel a burning or stinging sensation, which lasts a few minutes. The liquid nitrogen freezes and kills the abnormal skin cells and creates a wound.
What to expect after
The treated area will be sore and red. A blister may form soon after. A few days later, a crust will form on the wound. The dead tissue will start to fall off 1–6 weeks later, depending on the area treated. New, healthy skin cells will grow and a scar may develop. The healed skin may look paler than the surrounding skin.
Your doctor will tell you about follow-ups to check if the skin cancer has come back. In some cases, the procedure may need to be repeated.
Learn more about the different types of skin cancer.
→ READ MORE: Topical treatments for skin cancer
Podcast: Making Treatment Decisions
Listen to more podcasts for people affected by cancer
All updated content has been clinically reviewed by Prof Victoria Mar, Director, Victorian Melanoma Service, Alfred Hospital and Monash University, VIC and Prof Anne Cust, Acting Director, The Daffodil Centre, The University of Sydney and Cancer Council NSW, and faculty member, Melanoma Institute Australia. This edition is based on the previous edition, which was reviewed by the following panel: Prof Victoria Mar (see above); Tracey Bilson, Consumer; Raelene Buchan, Consumer; Alison Button-Sloan, Consumer; Dr Margaret Chua, Radiation Oncologist, and the Skin Radiation Oncology team, Peter MacCallum Cancer Centre, VIC; Prof Anne Cust, (see above); A/Prof Paul Fishburn, Skin Cancer Doctor, Norwest Skin Cancer Centre, NSW and Faculty of Medicine, University of Queensland; Danielle Goss, Melanoma Clinical Nurse Specialist, Amie St Clair Melanoma (part of Melanoma Institute Australia), Wagga Wagga, NSW; Louise Pellerade, 13 11 20 Consultant, Cancer Council WA; Dr Shireen Sidhu, Head of Dermatology, The Royal Adelaide Hospital, SA; Dr Amelia Smit, Research Fellow – Melanoma and Skin Cancer, The Daffodil Centre, The University of Sydney and Cancer Council NSW; Dr Tony Tonks, Plastic and Reconstructive Surgeon, Canberra Plastic Surgery, ACT. We also thank the health professionals, consumers and editorial teams who have worked on previous editions of this title. Thanks also to Sydney Melanoma Diagnostic Centre for providing the dysplastic naevus photograph on page 11, A/Prof Paul Fishburn for providing the sunspot photograph on page 10, A/Prof Andrew Miller for providing the age spot photograph on page 10, and Prof H Peter Soyer for providing the other photographs on pages 9–11.
View the Cancer Council NSW editorial policy.
